SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001610618-24-000005
Filing Date
2024-02-23
Accepted
2024-02-23 16:05:14
Documents
4
Period of Report
2024-04-04

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT cdtxpre14a02-23x2024.htm PRE 14A 414838
2 GRAPHIC cdtx_pcx2024smxpg1.jpg GRAPHIC 2953661
3 GRAPHIC cdtx_pcx2024smxpg2.jpg GRAPHIC 2462770
4 GRAPHIC cdtxlogoa13a.jpg GRAPHIC 46741
  Complete submission text file 0001610618-24-000005.txt   7918577
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36912 | Film No.: 24671109
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)